A Clinico-Comparative trial to study the effects of Bhallatakadi Churna and Hingwadi Churna in the Management of Amavata.

Not Applicable

• Conditions: Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

• Registration Number: CTRI/2020/06/026129
• Lead Sponsor: Government Akhandanand Ayurved Mahavidhyalaya

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patient having classical signs & symptoms of Amavata mentioned in Classical texts will be selected.

����मर�द�Sर��िस�त�ष�णा �लस�य� ��रव� ��वर: |

�पा�: श�नता��ानामामवातस�य ल��षणम� || [मा.नि]

ï?¼ According to American College of Rheumatology 2010,

1. Present with typically RA pain and stiffness in multiple joints

2.Morning stiffness lasting more than one hour

3. Boggy swelling due to synovitis

4. Present with more indolent arthralgia before onset of clinically apparent joint

swelling and low grade fever.

Age : Patients will be selected between 18 to 60 years of age.

Exclusion Criteria

1.The patients suffering from systemic disorders like Cardiac disease, Cancer,

Tuberculosis, and other debilitating diseases which may lead to fatal condition for the

Patient at any time.

2. Patients below 18 year and above 60 year will be excluded.

3.Patients of chronic condition (more than 3 years will be excluded.)

4.Patients having uncontrolled DM, Hypertention etc. will be excluded.

5.Patient suffering with Asadhya Lakshana as â??Sarva Dehchara Shothaâ?? and other such

Lakshana mentioned in Ayurvedic classics.

6.Patients diagnosed with Ayurveda diagnosis like Sandhivata, Sarvanga Vata etc. will be

excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Results will be assessed on the basis of relief in signs and symptoms of Amavata by specific scoring pattern.Timepoint: 6 Weeks.

Secondary Outcome Measures

Name	Time	Method
By comparing the effects of both the drugs on ESR and RA TITER before and after treatment.Timepoint: 6 Weeks.